Doctors Warn Against Medicines With Codeine After New FDA Cough And Cold Drug Requirements

BALTIMORE (WJZ) — The U.S. Food and Drug Administration will now require safety labeling changes to limit the use of prescription opioid cough and cold medicines.
These requirements made on Thursday pertain to medicines containing codeine or hydrocodone in children younger than 18-years-old. After the safety labeling changes are made, the products will no longer be indicated for use to treat coughs in any pediatric population. Instead, they will be labeled for use only in adults aged